|

ChatBot and Activity Monitoring in Patients Undergoing Chemoradiotherapy

RECRUITINGPhase 2Sponsored by Abramson Cancer Center at Penn Medicine
Actively Recruiting
PhasePhase 2
SponsorAbramson Cancer Center at Penn Medicine
Started2023-05-22
Est. completion2025-12
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site

Summary

Evaluate the feasibility of using a chatbot combined with continuous activity monitoring to proactively identify, appropriately triage and help manage patients' symptoms during cancer treatment Determine whether such an early outpatient clinic-based intervention can decrease rates of excess triage visits Correlate changes in activity and early symptom management to emergency department visits, unplanned inpatient hospitalizations and treatment breaks

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Adults (age \>18 years) with a diagnosis of a head and neck, lung, gastrointestinal cancer, that are receiving concurrent chemotherapy and radiation treatment.
* Possession of a mobile device that can receive SMS texts and can deliver FitBit data wirelessly
* Ability read and respond in English
* Ability to provide informed consent to participate in the study

Exclusion Criteria:

* Patients who are bed bound at baseline (ECOG 4)
* Patients who rely on a wheelchair for ambulation

Conditions4

CancerGastrointestinal CancerHead and Neck CancerLung Cancer

Locations1 site

Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104
Arun Goel, MD215-662-6059Arun.Goel@pennmedicine.upenn.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.